{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:43:57Z","timestamp":1761561837542},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10549-014-2864-3","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T09:20:22Z","timestamp":1392110422000},"page":"379-389","source":"Crossref","is-referenced-by-count":17,"title":["Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study"],"prefix":"10.1007","volume":"144","author":[{"given":"Aur\u00e9lie","family":"Ayme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Viassolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Rapiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rald","family":"Fioretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyma","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bouchardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre O.","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"issue":"5","key":"2864_CR1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","volume":"71","author":"PD Pharoah","year":"1997","unstructured":"Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71(5):800\u2013809","journal-title":"Int J Cancer"},{"key":"2864_CR2","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389\u20131399","DOI":"10.1016\/S0140-6736(01)06524-2"},{"issue":"3","key":"2864_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2864_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0004.2012.01859.x","volume":"82","author":"F Lalloo","year":"2012","unstructured":"Lalloo F, Evans DG (2012) Familial breast cancer. Clin Genet 82(2):105\u2013114","journal-title":"Clin Genet"},{"issue":"5","key":"2864_CR5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2009.27.0660","volume":"28","author":"ME Robson","year":"2010","unstructured":"Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K, American Society of Clinical Oncology (2010) American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28(5):893\u2013901","journal-title":"J Clin Oncol"},{"issue":"13","key":"2864_CR6","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S0959-8049(98)00208-1","volume":"34","author":"LA Dawson","year":"1998","unstructured":"Dawson LA, Chow E, Goss PE (1998) Evolving perspectives in contralateral breast cancer. Eur J Cancer 34(13):2000\u20132009","journal-title":"Eur J Cancer"},{"issue":"10","key":"2864_CR7","first-page":"855","volume":"8","author":"Y Chen","year":"1999","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855\u2013861","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2864_CR8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/ejso.1999.0711","volume":"25","author":"J Kollias","year":"1999","unstructured":"Kollias J, Ellis IO, Elston CW, Blamey RW (1999) Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol 25(6):584\u2013589","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"2864_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1470-2045(05)70174-1","volume":"6","author":"M Hartman","year":"2005","unstructured":"Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377\u2013382","journal-title":"Lancet Oncol"},{"issue":"2","key":"2864_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.breast.2010.10.004","volume":"20","author":"KR Beckmann","year":"2011","unstructured":"Beckmann KR, Buckingham J, Craft P, Dahlstrom JE, Zhang Y, Roder D, Stuart-Harris R (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158\u2013164","journal-title":"Breast"},{"issue":"35","key":"2864_CR11","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","volume":"27","author":"MK Graeser","year":"2009","unstructured":"Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887\u20135892","journal-title":"J Clin Oncol"},{"issue":"14","key":"2864_CR12","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2009.24.2495","volume":"28","author":"KE Malone","year":"2010","unstructured":"Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD Jr, Anton-Culver H, Bernstein JL (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404\u20132410","journal-title":"J Clin Oncol"},{"issue":"9","key":"2864_CR13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/bjc.2011.120","volume":"104","author":"K Metcalfe","year":"2011","unstructured":"Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384\u20131392","journal-title":"Br J Cancer"},{"issue":"11","key":"2864_CR14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ, Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H, Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF, On behalf of EMBRACE (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u20138225","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2864_CR15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1099-1611(200011\/12)9:6<504::AID-PON491>3.0.CO;2-R","volume":"9","author":"C Julian-Reynier","year":"2000","unstructured":"Julian-Reynier C, Sobol H, Sevilla C, Nogues C, Bourret P, French Cancer Genetic N (2000) Uptake of hereditary breast\/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psychooncology 9(6):504\u2013510","journal-title":"Psychooncology"},{"issue":"6","key":"2864_CR16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1099-1611(200011\/12)9:6<522::AID-PON492>3.0.CO;2-S","volume":"9","author":"L Hagoel","year":"2000","unstructured":"Hagoel L, Dishon S, Almog R, Silman Z, Bisland-Becktell S, Rennert G (2000) Proband family uptake of familial-genetic counselling. Psychooncology 9(6):522\u2013527","journal-title":"Psychooncology"},{"key":"2864_CR17","doi-asserted-by":"crossref","unstructured":"Brooks L, Lennard F, Shenton A, Lalloo F, Ambus I, Ardern-Jones A, Belk R, Kerr B, Craufurd D, Eeles R, Evans DG (2004) BRCA1\/2 predictive testing: a study of uptake in two centres. Eur J Hum Genet 12(8):654\u2013662","DOI":"10.1038\/sj.ejhg.5201206"},{"issue":"2","key":"2864_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10689-004-7991-2","volume":"4","author":"K Landsbergen","year":"2005","unstructured":"Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N (2005) Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 4(2):115\u2013119","journal-title":"Fam Cancer"},{"issue":"2","key":"2864_CR19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1399-0004.2008.01146.x","volume":"75","author":"DG Evans","year":"2009","unstructured":"Evans DG, Binchy A, Shenton A, Hopwood P, Craufurd D (2009) Comparison of proactive and usual approaches to offering predictive testing for BRCA1\/2 mutations in unaffected relatives. Clin Genet 75(2):124\u2013132","journal-title":"Clin Genet"},{"issue":"3","key":"2864_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10689-009-9313-1","volume":"9","author":"J Sanz","year":"2010","unstructured":"Sanz J, Ramon y Cajal T, Torres A, Darder E, Gadea N, Velasco A, Fortuny D, Lopez C, Fisas D, Brunet J, Alonso MC, Balmana J (2010) Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam Cancer 9(3):297\u2013304","journal-title":"Fam Cancer"},{"issue":"5","key":"2864_CR21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1055-9965.EPI-05-0002","volume":"15","author":"ME Ropka","year":"2006","unstructured":"Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT (2006) Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev 15(5):840\u2013855","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2864_CR22","first-page":"381","volume":"9","author":"MD Schwartz","year":"2000","unstructured":"Schwartz MD, Hughes C, Roth J, Main D, Peshkin BN, Isaacs C, Kavanagh C, Lerman C (2000) Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev 9(4):381\u2013385","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2864_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1009463905057","volume":"9","author":"SB Clark","year":"2000","unstructured":"Clark SB, Bluman LG, Borstelmann N, Regan K, Winer EP, Rimer BK, Skinner CS (2000) Patient motivation, satisfaction, and coping in genetic counseling and testing for BRCA1 and BRCA2. J Genet Couns 9(3):219\u2013235","journal-title":"J Genet Couns"},{"issue":"3","key":"2864_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/10906570050501489","volume":"4","author":"ME Wood","year":"2000","unstructured":"Wood ME, Mullineaux L, Rahm AK, Fairclough D, Wenzel L (2000) Impact of BRCA1 testing on women with cancer: a pilot study. Genet Test 4(3):265\u2013272","journal-title":"Genet Test"},{"issue":"6","key":"2864_CR25","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/cncr.25638","volume":"117","author":"C Bouchardy","year":"2011","unstructured":"Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria JC, Vlastos G, Rapiti E (2011) Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer 117(6):1288\u20131295","journal-title":"Cancer"},{"key":"2864_CR26","volume-title":"Cancer incidence in five continents","author":"MP Curado","year":"2007","unstructured":"Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications No 160, Lyon"},{"key":"2864_CR27","unstructured":"Percy C, Fritz A, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva"},{"key":"2864_CR28","volume-title":"TNM classification of malignant tumours, UICC","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind Ch (2002) TNM classification of malignant tumours, UICC, 6th edn. Wiley, New York","edition":"6"},{"issue":"2","key":"2864_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjc.6602914","volume":"94","author":"HM Verkooijen","year":"2006","unstructured":"Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G, Fioretta G, Sarp S, Sappino AP, Schubert H, Bouchardy C (2006) Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer 94(2):231\u2013238","journal-title":"Br J Cancer"},{"issue":"2","key":"2864_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/pmed.1999.0610","volume":"30","author":"K Bosompra","year":"2000","unstructured":"Bosompra K, Flynn BS, Ashikaga T, Rairikar CJ, Worden JK, Solomon LJ (2000) Likelihood of undergoing genetic testing for cancer risk: a population-based study. Prev Med 30(2):155\u2013166","journal-title":"Prev Med"},{"issue":"1","key":"2864_CR31","first-page":"89","volume":"11","author":"JL Bottorff","year":"2002","unstructured":"Bottorff JL, Ratner PA, Balneaves LG, Richardson CG, McCullum M, Hack T, Chalmers K, Buxton J (2002) Women\u2019s interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. Cancer Epidemiol Biomarkers Prev 11(1):89\u201395","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2864_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-013-2669-9","volume":"141","author":"P Pujol","year":"2013","unstructured":"Pujol P, Lyonnet DS, Frebourg T, Blin J, Picot MC, Lasset C, Dugast C, Berthet P, de Paillerets BB, Sobol H, Grandjouan S, Soubrier F, Buecher B, Guimbaud R, Lidereau R, Jonveaux P, Houdayer C, Giraud S, Olschwang S, Nogue E, Galibert V, Bara C, Nowak F, Khayat D, Nogues C (2013) Lack of referral for genetic counseling and testing in BRCA1\/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Breast Cancer Res Treat 141(1):135\u2013144","journal-title":"Breast Cancer Res Treat"},{"issue":"8899","key":"2864_CR33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343(8899):692\u2013695","journal-title":"Lancet"},{"issue":"11","key":"2864_CR34","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"EB Claus","year":"1996","unstructured":"Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77(11):2318\u20132324","journal-title":"Cancer"},{"issue":"3","key":"2864_CR35","first-page":"496","volume":"60","author":"AS Whittemore","year":"1997","unstructured":"Whittemore AS, Gong G, Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60(3):496\u2013504","journal-title":"Am J Hum Genet"},{"key":"2864_CR36","doi-asserted-by":"crossref","unstructured":"Anglian Breast Cancer Study Group\u00a0(2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83(10):1301\u20131308","DOI":"10.1054\/bjoc.2000.1407"},{"issue":"5","key":"2864_CR37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2864_CR38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333","journal-title":"J Clin Oncol"},{"issue":"2","key":"2864_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2864_CR40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t\u2019veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967\u2013975","journal-title":"JAMA"},{"key":"2864_CR41","unstructured":"NCCN Clinical Practice Guidelines in Oncology (2010) Genetic\/familial high-risk assessment: breast and ovarian, version 4.2013. www.nccn.org"},{"issue":"1","key":"2864_CR42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.02.017","volume":"113","author":"ACOG Committee on Pratice Bulletins","year":"2009","unstructured":"ACOG Committee on Pratice Bulletins (2009) Hereditary breast and ovarian cancer syndrome. Gynecol Oncol 113(1):6\u201311","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2864_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12687-011-0042-4","volume":"2","author":"D Gadzicki","year":"2011","unstructured":"Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, Tibben A, van Asperen CJ, Schlegelberger B (2011) Genetic testing for familial\/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet 2(2):53\u201369","journal-title":"J Community Genet"},{"issue":"6","key":"2864_CR44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1200\/JCO.2008.16.3691","volume":"27","author":"RT Zon","year":"2009","unstructured":"Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, Wollins DS, Garber JE, Brown P, Kramer BS, American Society of Clinical Oncology (2009) American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol 27(6):986\u20139931","journal-title":"J Clin Oncol"},{"issue":"1","key":"2864_CR45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-010-1137-z","volume":"127","author":"C Bouchardy","year":"2011","unstructured":"Bouchardy C, Benhamou S, Fioretta G, Verkooijen HM, Chappuis PO, Neyroud-Caspar I, Castiglione M, Vinh-Hung V, Vlastos G, Rapiti E (2011) Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Res Treat 127(1):233\u2013241","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2864_CR46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/annonc\/mdh072","volume":"15","author":"HM Verkooijen","year":"2004","unstructured":"Verkooijen HM, Fioretta G, Chappuis PO, Vlastos G, Sappino AP, Benhamou S, Bouchardy C (2004) Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol 15(2):350\u2013353","journal-title":"Ann Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-2864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2864-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:47:27Z","timestamp":1559234847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-2864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2864"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-2864-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]}}}